Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Philip Morris International Inc, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Philip Morris International Inc May 6, 202699.0%
-
Amneal Pharmaceuticals Inc. May 6, 202692.3%
-
Amneal Pharmaceuticals Inc. May 8, 202599.3%
-
Philip Morris International Inc May 8, 202498.8%
-
Amneal Pharmaceuticals Inc. May 2, 202499.6%
-
Amneal Pharmaceuticals Inc. May 9, 202399.2%
-
Philip Morris International Inc May 3, 202397.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2026 | Amneal Pharmaceuticals Inc. | Option exercise | +34,819 | — | — |
| May 6, 2026 | Philip Morris International Inc | Grant or award | +1,119 | $169.93 | $190,152 |
| May 7, 2025 | Philip Morris International Inc | Grant or award | +1,002 | $174.82 | $175,170 |
| May 5, 2025 | Amneal Pharmaceuticals Inc. | Option exercise | +40,258 | — | — |
| May 10, 2024 | Amneal Pharmaceuticals Inc. | Option exercise | +76,453 | — | — |
| May 8, 2024 | Philip Morris International Inc | Grant or award | +1,789 | $97.84 | $175,036 |
| May 10, 2023 | Amneal Pharmaceuticals Inc. | Option exercise | +80,128 | — | — |
| May 3, 2023 | Philip Morris International Inc | Grant or award | +1,812 | $96.58 | $175,003 |
Questions about Shlomo Yanai
What boards is Shlomo Yanai on?
Shlomo Yanai sits on the boards of Amneal Pharmaceuticals Inc. and Philip Morris International Inc.
How long has Shlomo Yanai served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.